View Post

How an existing diabetes drug controls pancreatic cancer

In In The News by Barbara Jacoby

By: Catharine Paddock PhD From: medicalnewstoday.com New research suggests that targeting a particular cell signaling pathway with the diabetes drug metformin might offer a way to stop the progression and spread of pancreatic cancer. The study — which was led by Rutgers Cancer Institute of New Jersey in New Brunswick — is to feature at the 2018 annual meeting of …

View Post

Bacteria and Cancer: Another Connection

In In The News by Barbara Jacoby

By: Derek Lowe From: sciencemag.org  Three months ago, I wrote about a report that some kinds of pancreatic cancer seem to be associated with particular infections, and wondered “How many similar stories are out there that we don’t know about yet?” Well, that didn’t take long to start being answered. This recent paper in Science (from a multicenter team: Dana-Farber, Broad, …

View Post

Extreme Early Detection Intrigues Cancer Researchers

In In The News by Barbara Jacoby

By: Faye Flam From: bloomberg.com Many tumors grow silently for years before they cause any symptoms. Oncologists see an opportunity. There’s only so far you can go toward preventing cancer with a healthy lifestyle. Bone tumors in fossils show that people have been getting cancer since prehistoric times — before smoking, before modern diets, even before the dawn of our …

View Post

OHSU kicks off initiative to personalize clinical trials for cancer

In In The News by Barbara Jacoby

By: Tom Sullivan From: healthcareitnews.com Oregon Health & Science University on Thursday announced a new research project to create personalized clinical trials for cancers, including breast, pancreatic and prostate. With the new initiative, OHSU joins a growing number of academic medical centers and hospitals undertaking precision medicine initiatives focused specifically on cancer, including Swedish Cancer Institute and Intermountain Healthcare in …

View Post

Pancreatic cancer trial: Early surgery boosts success rates

In In The News by Barbara Jacoby

From: bbc.com Speeding up access to surgery for pancreatic cancer patients diagnosed early enough increased success rates by a third, a pilot scheme has shown. The Birmingham team said it had saved the NHS £3,200 per patient and could help hundreds of patients UK-wide. The trial involved cutting average time to surgery for 32 patients from two months to just …

View Post

FDA Approves Pembrolizumab for Pancreatic Cancers with Mismatch Repair Deficiency

In In The News by Barbara Jacoby

Source: The Lustgarten Foundation for Pancreatic Cancer Research From: PR Newswire In an unprecedented, fast-tracked review, the Food and Drug Administration (FDA) approved the use of pembrolizumab (anti-PDI) immunotherapy for patients with advanced pancreatic cancers who have a defect in their capacity to repair DNA.  Support from the Lustgarten Foundation was critical to the success of the clinical trial that …

View Post

Cancer spreads even before tumours form

In In The News by Barbara Jacoby

By: Sushmi Dey, TNN From: economictimes.indiatimes.com In a new discovery that might challenge the existing knowledge of cancer and methods to treat it, researchers have found cancer cells spread to organs much earlier than was thought. In fact, cancer cells can spread even before a tumour develops, remain quiet for long periods of time and then awaken to form aggressive …

View Post

New Treatment Offering Hope To Pancreatic Cancer Patients

In In The News by Barbara Jacoby

By: Dr. Maria Simbra From: pittsburgh.cbslocal.com A cancer diagnosis is never a good thing, but pancreatic cancer is especially bad. The chances of surviving it aren’t great, but there’s a new treatment that’s offering hope. Leslie Wineberg exercised every day, maintained her weight and took good care of herself. When she developed abdominal pain and couldn’t eat, she saw her …

View Post

Drug stops spread of melanoma by up to 90% – and it could be used to treat breast and pancreatic cancer

In In The News by Barbara Jacoby

By: Hannah Osborne From: ibtimes.co.uk A chemical compound has been developed that can stop the spread of melanoma by up to 90%. This is one of the first potential drugs that targets metastasis rather than killing cells – and researchers say it could be applied to other diseases, including breast and pancreatic cancer. Researchers from Michigan State University were building …

View Post

Study uncovers mechanism that causes chemo resistance of pancreatic cancer cells

In In The News by Barbara Jacoby

Source: University of Liverpool From: www.news-medical.net A pioneering University of Liverpool research team have published a study that identifies the mechanism in the human body that causes resistance of pancreatic cancer cells to chemotherapy. Pancreatic cancer is one of the leading causes of cancer death and current therapies are not very effective. Thus, a better understanding of the molecular mechanisms …